Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page
- ChecktodayChange DetectedRecruitment status updated from Recruiting to Active, not recruiting as of 2025-12-15, and new sections were added (Contacts/Locations, Eligibility, Study Design, Study Status, Recruitment Status) with version 9 dated 2025-12-12, replacing the earlier Recruiting entry from 2025-01-27.SummaryDifference1.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision v3.3.2 has been added to the Record History, and the previous v3.2.0 entry has been removed.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the funding-lapse notice about website operation status. The study record details and history remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedNew version added on 2025-01-23 with a Study Status update to the history; previous entries show Recruitment Status updates.SummaryDifference0.1%

- Check72 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference13%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.3%

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.